Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry

INTRODUCTION: Aim of this study was to assess the impact of the introduction of new class of drugs (ARNI: angiotensin receptor-neprilysin inhibitor) on hospital related costs in a real world cohort of patients with chronic heart failure (CHF). METHODS: Seventy-three consecutive patients with CHF and...

Descripción completa

Detalles Bibliográficos
Autores principales: Correale, Michele, Monaco, Ilenia, Ferraretti, Armando, Tricarico, Lucia, Padovano, Giuseppina, Formica, Ennio Sascia, Tozzi, Valeria, Grazioli, Davide, Di Biase, Matteo, Brunetti, Natale Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437279/
https://www.ncbi.nlm.nih.gov/pubmed/30963090
http://dx.doi.org/10.1016/j.ijcha.2018.12.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437279/
https://www.ncbi.nlm.nih.gov/pubmed/30963090
http://dx.doi.org/10.1016/j.ijcha.2018.12.009

Ejemplares similares